Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strains

Cold-adapted-viral-attenuation (CAVA) and novel attenuated poliovirus strains

US Patent 10238730 · Granted Mar 26, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Potent and short promoter for expression of heterologous genes2024
Potent and short promoter for expression of heterologous genes2024
Vaccines based on mutant CALR and JAK2 and their uses2024
Adenovirus and uses thereof2024
Adenovirus and uses thereof2024
Poxvirus vectors encoding HIV antigens, and methods of use thereof2023
Recombinant adenoviral vector expressing Zika antigen with improved productivity2023
Adenovirus vectors and uses thereof2022
Adenovirus vectors and uses thereof2022
Articles for diagnosis of liver fibrosis2022
Adenovirus and uses thereof2022
Adenovirus and uses thereof2022